## Abstract ## Background Peritoneal carcinomatosis is a common evolution of many abdominal and pelvic malignancies. Over the last decade novel therapeutic approaches have emerged combining cytoreductive surgery with perioperative intraperitoneal chemotherapy. Aim of our study was to assess freque
Intraoperative and postoperative effects of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: Results from a monocentric retrospective study
β Scribed by Muffatti, F.; Orsenigo, E.; Socci, C.; Chiari, D.; Totaro, L.; Staudacher, C.
- Book ID
- 122877850
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 39 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0748-7983
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for selected patients with peritoneal carcinomatosis arising from colorectal cancer. Due to the aggressive surgery the concept is associated with a significa
## Abstract ## BACKGROUND Hyperthermic intraperitoneal intraoperative chemotherapy (HIIC) combined with cytoreductive surgery (CS) has been proposed as a new multimodal treatment mainly for carcinomatosis of gastrointestinal origin. To evaluate whether this regimen could be used for other tumor ty